esketamine has been researched along with Hallucinations in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borentain, S; Drevets, WC; Singh, JB; Turkoz, I; Wajs, E; Williamson, D | 1 |
| Kamphuis, J; Schlegel, M; Schoevers, RA; Veraart, JKE | 1 |
1 trial(s) available for esketamine and Hallucinations
| Article | Year |
|---|---|
Adverse Events and Measurement of Dissociation After the First Dose of Esketamine in Patients With TRD.
Topics: Antidepressive Agents; Depressive Disorder, Treatment-Resistant; Hallucinations; Humans; Ketamine; Psychotic Disorders | 2023 |
1 other study(ies) available for esketamine and Hallucinations
| Article | Year |
|---|---|
Oral S-ketamine effective after deep brain stimulation in severe treatment-resistant depression and extensive comorbidities.
Topics: Administration, Oral; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Clozapine; Deep Brain Stimulation; Depressive Disorder, Treatment-Resistant; Electroconvulsive Therapy; Female; Glycopyrrolate; Hallucinations; Humans; Ketamine; Middle Aged; Muscarinic Antagonists; Nitrazepam; Obsessive-Compulsive Disorder; Treatment Failure; Venlafaxine Hydrochloride | 2021 |